• English
  • Español
  • Русский
  • 中文
  • العربية

Most reported cases related to Parkinson´s disease have unknown causes. Hence, researchers continue to study and debate about the likely causes to the illness. According to recent research published on “NPJ Parkinson’s Disease”, specific influenza virus makes mice acquire the same symptoms as those in Parkinson’s disease.

According to a study carried out by neuroscience experts, environmental factors such as influenza could potentially lead to developing some symptoms of Parkinson’s disease. This study proves that mice that overcome H1N1 influenza virus are highly prone to any chemical toxin that can lead to Parkinson’s. H1N1 viruses increase the risk of Parkinson’s disease.

This research shows that even mice that suffered from influenza virus (H1N1) and recovered are behind the former pandemic (Swine flu). In addition, these mice are susceptible to any chemical toxin that leads to Parkinson’s disease in the laboratory. H5N1 (bird flu) has the capability to increase the risk of Parkinson’s disease. H5N1 can kill over 60 percent of the people infected with Bird Flu.

If this deadly virus reaches the brain through the infection of nerve cells, they can cause inflammation.
When brain inflammation takes a long time to cure, such as many cases of head injury, it can lead to an increased risk of Parkinson’s disease.

Unlike H5N1, H1N1 virus is less deadly, thus it has zero effects on neurons. H1N1 is a swine flu, which causes the body´s immune system to produce cytokines (cytokines is one of the inflammatory chemicals that affect the brain).
Even though H1N1 is not very deadly as such, its strain can lead to inflammation. This is because our immune system releases molecules.

Using MPTP as a toxin, researchers provoked Parkinson’s symptoms in two different mice categories. One category had H1N1 virus infection, which showed serious signs of Parkinson’s. The second category had toxin exposure only. The second group responded positively to H1N1 vaccinations.
Since the last group did not have H1N1 virus infections, it also responded well to Tamiflu – one of the antiviral medications.

H1N1 is “Type A” influenza. Researchers believe that these results are worth studying further to improve substantially in current understanding at this point. When a deadly virus such as H1N1 affects the body, the immune system will release toxic chemicals. In such cases, the body needs to be resilient to these toxic elements.

And, it can only do this with the help of antiviral medications or seasonal-flu vaccinations. In so doing, the body will recover fully in the shortest time possible without causing impacts to the brain.

Share StemCells21